lobbying_activities: 632969

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
632969	a8bbebd5-24e1-4b90-9ce3-97e89cae20c9	Q2	BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC	292972	BOEHRINGER INGELHEIM USA CORPORATION	2008	second_quarter	ANI	Reauthorization of the Animal Drug User Fee Act, no specific legislation	HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of		300619	0	0	2008-07-17T11:01:17-04:00